BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27124741)

  • 1. Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
    Ren Y; Gu Y; Wang W; Wang J; Li X; Wang Y; Gao H; Dong X; Tian Y
    Cell Cycle; 2016 Jun; 15(12):1545-51. PubMed ID: 27124741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
    Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
    Zhan HQ; Zhu XZ; Li XQ; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
    Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
    Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma.
    Hong H; Fang X; Huang H; Wang Z; Lin T; Yao H
    Br J Haematol; 2020 Jun; 189(5):908-912. PubMed ID: 32103494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan.
    Kao HW; Lin TL; Shih LY; Dunn P; Kuo MC; Hung YS; Wu JH; Tang TC; Chang H; Kuo TT; Ou CW; Wang PN
    Int J Hematol; 2016 Aug; 104(2):256-65. PubMed ID: 27095042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
    Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
    Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
    Mourad N; Mounier N; Brière J; Raffoux E; Delmer A; Feller A; Meijer CJ; Emile JF; Bouabdallah R; Bosly A; Diebold J; Haioun C; Coiffier B; Gisselbrecht C; Gaulard P;
    Blood; 2008 May; 111(9):4463-70. PubMed ID: 18292286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.
    Nihal M; Ahmad N; Wood GS
    Cell Cycle; 2014; 13(4):632-40. PubMed ID: 24343700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL).
    Du J; Qiu C; Li WS; Wang B; Han XL; Lin SW; Fu XH; Hou J; Huang ZF
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):270. PubMed ID: 36224014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine for angioimmunoblastic T-cell lymphoma: a literature review.
    Ohmoto A; Fuji S
    Expert Rev Hematol; 2019 Nov; 12(11):975-981. PubMed ID: 31393197
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience.
    Lin HN; Liu CY; Hong YC; Pai JT; Yang CF; Yu YB; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Tzeng CH; Chen PM
    Leuk Lymphoma; 2010 Dec; 51(12):2208-14. PubMed ID: 21054150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
    Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
    Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
    Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma.
    Moon SH; Lee AY; Kim WS; Kim SJ; Cho YS; Choe YS; Kim BT; Lee KH
    Leuk Lymphoma; 2017 Jun; 58(6):1341-1348. PubMed ID: 27718766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics.
    Attygalle AD; Chuang SS; Diss TC; Du MQ; Isaacson PG; Dogan A
    Histopathology; 2007 Mar; 50(4):498-508. PubMed ID: 17448026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
    Peng W; Wu J; Feng J
    Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognosis in 84 patients with angioimmunoblastic T-cell lymphoma: a single-center analysis].
    Li TT; Luo LT; Chen Y; Yang T; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):915-920. PubMed ID: 33333694
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of spleen is associated with shorter survival in patients with angioimmunoblastic T cell lymphoma.
    Huang Y; Zeng R; Xue C; Huang Q; Yu D; Shao L; Zhou H; Wu H
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9721-9726. PubMed ID: 37244875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL).
    Niino D; Komohara Y; Murayama T; Aoki R; Kimura Y; Hashikawa K; Kiyasu J; Takeuchi M; Suefuji N; Sugita Y; Takeya M; Ohshima K
    Pathol Int; 2010 Apr; 60(4):278-83. PubMed ID: 20403029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.